Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans

Rungnapa Boonpawa*, Bert Spenkelink, Ans Punt, Ivonne Rietjens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Abstract

Scope: To develop a physiologically based kinetic (PBK) model that describes the absorption, distribution, metabolism, and excretion of hesperidin in humans, enabling the translation of in vitro concentration-response curves to in vivo dose-response curves. Methods and results: The PBK model for hesperidin in humans was developed based on in vitro metabolic parameters. Hesperidin was predicted to mainly occur in the systemic circulation as different monoglucuronides. The plasma concentrations of hesperidin aglycone (hesperetin) was predicted to be <0.02 mg/L at an oral dose of 50 mg/kg bw. The developed PBK model allowed conversion of in vitro concentration-response curves for different effects to in vivo dose-response curves. The BMD05 (benchmark dose for 5% response) values for protein kinase A inhibition ranged between 135 and 529 mg/kg bw hesperidin, and for inhibition of endothelial cell migration and prostaglandin E2 and nitric oxide production ranged between 2.19 and 44 mg/kg bw hesperidin. These values are in line with reported human data showing in vivo effects by hesperidin and show that these effects may occur at Western dietary and supplementary intake of hesperidin. Conclusions: The developed PBK model adequately predicts absorption, distribution, metabolism, and excretion of hesperidin in humans and allows to evaluate the human in vivo situation without the need for human intervention studies.
Original languageEnglish
Article number1600894
JournalMolecular Nutrition & Food Research
Volume61
Issue number8
DOIs
Publication statusPublished - 2017

Keywords

  • ADME
  • Hesperetin metabolites
  • Hesperidin
  • In vitro-in vivo extrapolation
  • PBK modeling

Fingerprint

Dive into the research topics of 'Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans'. Together they form a unique fingerprint.

Cite this